Perbedaan Ristia Bintang Mahkotasejati Tbk. dan Organon Pharma Indonesia Tbk.: Ristia Bintang Mahkotasejati Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 162,03 M, volume 24 jam 15,21 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Ristia Bintang Mahkotasejati Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| RBMS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 162,03 M | 104,4 M |
Volume | 15,21 jt | — |
Lot | 152,08 rb | — |
Perputaran | 946,82 jt | — |
Harga Rata-rata | 62,26 | — |
Nilai Transaksi | 946,82 jt | — |
Harga Ekuilibrium Indikatif | 63 | — |
Volume Ekuilibrium Indikatif | 5,97 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ristia Bintang Mahkotasejati Tbk (the Company) was established based on the Notarial Deed No. 114 of Lieke Lianadevi Tukgali, S.H., dated May 22, 1985. PT. Ristia Bintang Mahkotasejati is a Real Estate developer and contractor. A company developing houses, store houses and also facilities supported in Bekasi, Tanggerang and Karawang.
Selengkapnya di halaman RBMS →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →